Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTM vs Steroid Injection for Lateral Epicondylitis
NCT06171555Phase 2Enrolling by invitation
- Sponsor
- Indiana Hand to Shoulder Center
- Start
- Jan 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Lateral Epicondylitis (LET) (2 arms), sponsored by Indiana Hand to Shoulder Center. Primary endpoint: Patient-Related Tennis Elbow Evaluation Pain Subscale at 6 months. Started Jan 2023; status: enrolling by invitation.
02
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT06171555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06171555.